sglt2 vs glp 1 Mechanisms of SGLT2i and GLP-1RAs in patients with T2DM. GLP-1 receptor SGLT-2 inhibitors or GLP-1 receptor

doi: 10.1186/s10020-024-01020-5 225 JianYZengYWangZZhouXZhangHLiangDet al

The LDL modification hypothesis of atherogenesis: an update

Instead, clinicians should acknowledge this risk and consider individualized risk-benefit strategies when prescribing GLP-1 RAs, particularly for patients with pre-existing ocular manifestations and must inform patients regarding possible ocular hazards while advocating for regular retinal examinations and assessments of visual acuity

FormBlends doesn't claim that CJC-1295 cures, treats, or prevents any disease

If your clinician feels compounded medications are clinically appropriate for you, any compounded medications are not approved by the FDA or reviewed for quality, safety or efficacy

doi: 10.1158/1940-6207.CAPR-16-0254 6 ParkJShinYKimTHKimDHLeeA